NSC |
Compound |
Enrichment |
Correlation |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0048681766467277 |
0.31127794 |
NSC 13484 |
Null |
0.0048681766467277 |
0.23299141 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.0048681766467277 |
0.42992314 |
NSC 354051 |
LISCUNDITRIN |
0.0048681766467277 |
0.20807305 |
NSC 375162 |
Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide |
0.0048681766467277 |
0.057765806 |
NSC 601679 |
Null |
0.0048681766467277 |
0.20037908 |
NSC 603084 |
2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- |
0.0048681766467277 |
0.41526674 |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.0048681766467277 |
0.28318111 |
NSC 623723 |
Null |
0.0048681766467277 |
0.16844097 |
NSC 632573 |
Tris(1,3-diphenylpropane-1,3-dionata)gallium(III) |
0.0048681766467277 |
0.15925143 |